Lee's Pharmaceutical Holdings Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LPCUF research report →
Companywww.leespharm.com
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. The company focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. It operates through Proprietary and Generic Products; and Licensed-In Products segments.
- CEO
- Siu Fong Lee
- IPO
- 2021
- Employees
- 1,022
- HQ
- Sha Tin, HK
Price Chart
Valuation
- Market Cap
- $112.06M
- P/E
- 6.89
- P/S
- 0.46
- P/B
- 0.32
- EV/EBITDA
- 2.73
- Div Yield
- 4.23%
Profitability
- Gross Margin
- 51.96%
- Op Margin
- 6.91%
- Net Margin
- 6.61%
- ROE
- 5.00%
- ROIC
- 2.61%
Growth & Income
- Revenue
- $1.44B · 2.55%
- Net Income
- $91.92M · -1.27%
- EPS
- $0.16 · 0.00%
- Op Income
- $61.47M
- FCF YoY
- 194.16%
Performance & Tape
- 52W High
- $0.20
- 52W Low
- $0.19
- 50D MA
- $0.19
- 200D MA
- $0.19
- Beta
- 0.57
- Avg Volume
- 3.24K
Get TickerSpark's AI analysis on LPCUF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LPCUF Coverage
We haven't published any research on LPCUF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LPCUF Report →